United Kingdom: Patent

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
EPO v UPC – Jurisdiction
Since the Unified Patent Court opened on 1 June 2023, one of the more interesting legal questions which has been considered is the matter of jurisdictional competence. Following on from our comparison of the EPO and UPC’s approaches to inventive step (available here) and as the dust begins to settle on some of the early decisions, it is a good time to reflect on the early decisions of the UPC in relation to jurisdiction and to compare the UPC with the EPO in this regard.
Worldwide IP
B
Boult Wade Tennant
Article
From Lab To Manufacturing: Why Scale-up Can Create New Patent Opportunities
For companies developing advanced materials, battery technologies, and green technologies, the journey from laboratory proof-of-concept to commercial manufacturing often reveals the most valuable patentable inventions. Scale-up challenges involving heat transfer, particle morphology, coating uniformity, and manufacturing economics can create intellectual property that proves more commercially significant than the original laboratory discovery.
United Kingdom IP
B
Boult Wade Tennant
Article
EPO Enlarged Board Of Appeal - The Definition Of "Inconsistency"
The European Patent Office's Enlarged Board of Appeal has issued a landmark decision in case G 1/25, fundamentally reshaping the requirements for adapting patent descriptions when claims are amended. The ruling establishes a narrow definition of "inconsistency" and rejects the previous practice of demanding wholesale clean-up of descriptions to remove all unclaimed subject-matter. Patent practitioners and applicants now face a more streamlined approach that focuses only on inconsistencies with genuine legal
United Kingdom IP
LS
Lewis Silkin
Article
From Start-Up Surge To Scale-Up Success: Why IP Matters More Than Ever
Scotland's technology start-up ecosystem is experiencing remarkable growth, with new business formation outpacing the rest of the UK. However, converting this entrepreneurial momentum into sustainable, scalable success requires founders to prioritize intellectual property protection from day one, as IP assets increasingly determine investment decisions and long-term competitive advantage.
United Kingdom IP
MC
Marks & Clerk
Article
Cleaning The (Patent) Pool: Supreme Court Opens The Door To Judicial Determination Of FRAND Rates For Patent Pool SEPs
The Supreme Court has confirmed that English courts can determine whether licensing terms offered by patent pools for standard essential patents (SEPs) are fair, reasonable and non-discriminatory (FRAND), even when the pool operator made no FRAND commitment and owns no SEPs. This landmark decision in Tesla v InterDigital opens the door to judicial scrutiny of patent pool rates and raises important questions about how SEP owners and implementers navigate collective licensing arrangements.
United Kingdom IP
SM
Slaughter & May
Article
A Reminder To Check Texts Proposed For Grant Carefully (T 0216/26)
A recent European Patent Office case highlights the consequences when drawing pages are inadvertently omitted from a text proposed for grant. While the Board of Appeal allowed the applicant's appeal to reinstate the missing pages, they denied reimbursement of the appeal fee, emphasizing that applicants bear responsibility for carefully reviewing proposed grant texts before approval.
United Kingdom IP
B
Boult Wade Tennant
Article
Priority Patent Applications For Biotech And Chemistry Startups
Biotechnology and chemistry startups face a critical question when filing priority patent applications: how much experimental data is actually required? While the answer depends on the predictability of the technology, the European Patent Office's strict disclosure standards mean that insufficient technical support can invalidate priority claims entirely, leaving innovations vulnerable to competitor filings and prior art that emerges during the assumed protection period.
United Kingdom IP
PC
Potter Clarkson
Article
Should Biotech Companies Like ValiRx Announce Patent Grants?
ValiRx's subsidiary Cytolytix has received positive signals from the European Patent Office regarding patent protection for its polyleucine-based anti-cancer peptides, raising questions about why the company is publicly announcing these intellectual property developments. The strategic timing and nature of these announcements may reveal important insights about the company's approach to attracting investment and licensing partners in the competitive biotechnology sector.
United Kingdom IP
MC
Marks & Clerk
See more